Disease / condition

Germ Cell Tumor clinical trials

Free access to 14 studies·7+ countries·Updated daily5 recruiting
14
Total trials
7+
Countries
9+
Sponsors
5
Recruiting
By phase
Phase 29
Phase 32
N/A2
Early Phase 11
By status
Recruiting5
Terminated3
Completed2
Unknown2
Not yet recruit...1
Top countries
Slovakia3
France3
United States of America2
United States of America;United Kingdom;India;Australia1
Russian Federation1
Top sponsors
National Cancer In...3
Gustave Roussy, Ca...3
Fondazione IRCCS I...1
Indiana University...1
Masonic Cancer Cen...1
Recent trials
Latest clinical trials for Germ Cell Tumor
NCT06418789·Phase 2Recruiting
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
N.N. Petrov National Medical R...Russian Federation
NCT05874063·Phase 3Not yet recr...
Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors
Gustave Roussy, Cancer Campus,...
NCT05889585Recruiting
Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated With High-dose Chemotherapy and Autologous Stem Cell Transplant
Gustave Roussy, Cancer Campus,...France
NCT03950830·Phase 2Recruiting
Disulfiram and Cisplatin in Refractory TGCTs.
National Cancer Institute, Slo...Slovakia
jRCTs031180410Recruiting
Untitled Trial
United States of America;United Kingdom;India;Australia
NCT03960151·Phase 2Withdrawn
Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy
Costantine Albany
NCT03081923·Phase 2Terminated
Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors
Fondazione IRCCS Istituto Nazi...Italy
NCT02988843·Phase 2Terminated
Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
Masonic Cancer Center, Univers...United States of America
NCT02582697·Phase 3Recruiting
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
University of SydneyAustralia,New Zealand,United States of America
NCT02414685·Phase 2Completed
First Line TIP in Poor Prognosis TGCTs.
National Cancer Institute, Slo...Slovakia
NCT01966913·Early Phase 1
Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors
Assistance Publique - Hôpitaux...France
NCT01466231·Phase 2Completed
Everolimus in Refractory Testicular Germ Cell Cancer
National Cancer Institute, Slo...Slovakia
NCT00198172·Phase 2Terminated
Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
Indiana University School of M...United States of America
NCT00127049·Phase 2
Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
Gustave Roussy, Cancer Campus,...France
About this record

Access comprehensive clinical trial information for Germ Cell Tumor through Pure Global AI's free database. This collection includes 14 clinical trials across multiple phases including Phase 2, Phase 3, N/A. Currently, 5 trials are actively recruiting participants.

Research for Germ Cell Tumor is being conducted in Slovakia, France, United States of America and 4+ other countries. Leading sponsors include National Cancer Institute, Slovakia and Gustave Roussy, Cancer Campus, Grand Paris. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 14 clinical trials studying Germ Cell Tumor, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 7+ countries.

Top research sponsors include National Cancer Institute, Slovakia, Gustave Roussy, Cancer Campus, Grand Paris, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, among others.